Anti-CST9L/ CTES7B/ bA218C14.1 functional antibody

Anti-CST9L/ CTES7B/ bA218C14.1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CST9L/CST9L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0130-Ab-1/ GM-Tg-hg-SE0130-Ab-2Anti-Human CST9L monoclonal antibodyHuman
GM-Tg-rg-SE0130-Ab-1/ GM-Tg-rg-SE0130-Ab-2Anti-Rat CST9L monoclonal antibodyRat
GM-Tg-mg-SE0130-Ab-1/ GM-Tg-mg-SE0130-Ab-2Anti-Mouse CST9L monoclonal antibodyMouse
GM-Tg-cynog-SE0130-Ab-1/ GM-Tg-cynog-SE0130-Ab-2Anti-Cynomolgus/ Rhesus macaque CST9L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0130-Ab-1/ GM-Tg-felg-SE0130-Ab-2Anti-Feline CST9L monoclonal antibodyFeline
GM-Tg-cang-SE0130-Ab-1/ GM-Tg-cang-SE0130-Ab-2Anti-Canine CST9L monoclonal antibodyCanine
GM-Tg-bovg-SE0130-Ab-1/ GM-Tg-bovg-SE0130-Ab-2Anti-Bovine CST9L monoclonal antibodyBovine
GM-Tg-equg-SE0130-Ab-1/ GM-Tg-equg-SE0130-Ab-2Anti-Equine CST9L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0130-Ab-1/ GM-Tg-hg-SE0130-Ab-2; GM-Tg-rg-SE0130-Ab-1/ GM-Tg-rg-SE0130-Ab-2;
GM-Tg-mg-SE0130-Ab-1/ GM-Tg-mg-SE0130-Ab-2; GM-Tg-cynog-SE0130-Ab-1/ GM-Tg-cynog-SE0130-Ab-2;
GM-Tg-felg-SE0130-Ab-1/ GM-Tg-felg-SE0130-Ab-2; GM-Tg-cang-SE0130-Ab-1/ GM-Tg-cang-SE0130-Ab-2;
GM-Tg-bovg-SE0130-Ab-1/ GM-Tg-bovg-SE0130-Ab-2; GM-Tg-equg-SE0130-Ab-1/ GM-Tg-equg-SE0130-Ab-2
Products NameAnti-CST9L monoclonal antibody
Formatmab
Target NameCST9L
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CST9L benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0130-Ag-1Recombinant multi-species CST9L/ CTES7B/ bA218C14.1 protein


    Target information

    Target IDGM-SE0130
    Target NameCST9L
    Gene ID128821
    Gene Symbol and SynonymsbA218C14.1,CST9L,CTES7B
    Uniprot AccessionQ9H4G1
    Uniprot Entry NameCST9L_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101435
    Target ClassificationN/A

    The target: CST9L, gene name: CST9L, also named as CTES7B, bA218C14.1. The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes a protein similar to mouse cystatin 9. Based on its testis-specific expression, it is likely to have a role in tissue reorganization during early testis development. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.